ACN Newswire Etrasimod Receives Strong Recommendation in the ACG Clinical Guideline Update: Ulcerative Colitis in Adults for Induction and Maintenance Phase of Moderately to Severely Active UC
ACN Newswire OrbusNeich Records Growth in 2025 Interim Results, Revenue and Net Profit Reach US$83.6 Million and US$19.8 Million Respectively
ACN Newswire MMG Announces 2025 Interim Results, Profit, Earnings and Cash up on Strong Copper Growth
ACN Newswire Everest Medicines’ New Drug Application for Etrasimod Accepted in Taiwan, Marking Another Milestone in Asia Market Access
ACN Newswire Yuexiu REIT Maintains Overall Operational Stability, Achieves Revenue of Over RMB966 Million
ACN Newswire AsiaMedic Reports 26% Revenue Growth to S$16.6 million in 1H2025, Led by Strong Diagnostic Imaging Performance
ACN Newswire Focus Graphite Advances ESIA Reporting at Lac Knife and Accelerates Mineral Resource Expansion at Lac Tetepisca and Announces the Grant of Options and RSUs
